Related Experiment Video
Updated: Dec 22, 2025

Phage Phenomics: Physiological Approaches to Characterize Novel Viral Proteins
Published on: June 11, 2015
Isolation and Characterization of Two Klebsiella pneumoniae Phages Encoding Divergent Depolymerases
Pilar Domingo-Calap1, Beatriz Beamud2, Lucas Mora-Quilis3
1Institute for Integrative Systems Biology, I2SysBio, Universitat de València-CSIC, and Department of Genetics, Universitat de València, 46980 Paterna, Spain.
Abstract:
The emergence of multidrug-resistant bacteria is a major global health concern. The search for new therapies has brought bacteriophages into the spotlight, and new phages are being described as possible therapeutic agents. Among the bacteria that are most extensively resistant to current antibiotics is Klebsiella pneumoniae, whose hypervariable extracellular capsule makes treatment particularly difficult. Here, we describe two new K. pneumoniae phages, πVLC5 and πVLC6, isolated from environmental samples. These phages belong to the genus Drulisvirus within the family Podoviridae. Both phages encode a similar tail spike protein with putative depolymerase activity, which is shared among other related phages and probably determines their ability to specifically infect K. pneumoniae capsular types K22 and K37. In addition, we found that phage πVLC6 also infects capsular type K13 and is capable of striping the capsules of K. pneumoniae KL2 and KL3, although the phage was not infectious in these two strains. Genome sequence analysis suggested that the extended tropism of phage πVLC6 is conferred by a second, divergent depolymerase. Phage πVLC5 encodes yet another putative depolymerase, but we found no activity of this phage against capsular types other than K22 and K37, after testing a panel of 77 reference strains. Overall, our results confirm that most phages productively infected one or few Klebsiella capsular types. This constitutes an important challenge for clinical applications.
Insights
Two new bacteriophages, πVLC5 and πVLC6, were isolated to combat multidrug-resistant Klebsiella pneumoniae. Their specific depolymerase activity targets certain capsular types, posing challenges for broad clinical use.
Area of Science:
- Microbiology
- Virology
- Biotechnology
Background:
- Multidrug-resistant bacteria, particularly Klebsiella pneumoniae, pose a significant global health threat.
- Bacteriophages are emerging as potential therapeutic agents against antibiotic-resistant infections.
- The hypervariable capsule of K. pneumoniae complicates treatment strategies.
Purpose of the Study:
- To isolate and characterize novel bacteriophages effective against Klebsiella pneumoniae.
- To investigate the host range and depolymerase activity of newly identified phages.
- To assess the potential of these phages for therapeutic applications against K. pneumoniae.
Main Methods:
- Isolation of bacteriophages from environmental samples.
- Phage characterization, including host range determination and genome sequencing.
- Analysis of tail spike protein and depolymerase activity against K. pneumoniae capsular types.
Main Results:
- Two new Klebsiella pneumoniae phages, πVLC5 and πVLC6, belonging to the Drulisvirus genus (Podoviridae family), were identified.
- Both phages exhibit depolymerase activity targeting capsular types K22 and K37.
- Phage πVLC6 shows broader tropism, infecting K13 and affecting K2 and K3 capsules due to a second depolymerase, while πVLC5 is specific to K22 and K37.
Conclusions:
- The characterized phages πVLC5 and πVLC6 demonstrate specific activity against certain Klebsiella pneumoniae capsular types.
- The presence of multiple depolymerases influences phage tropism, as seen in πVLC6.
- The limited host range of most phages presents a significant challenge for their widespread clinical application against K. pneumoniae.
Related Concept Videos
DNA Bacteriophages
Viral Replication: Lytic Cycle
Lysogenic Cycle of Bacteriophages
Lytic Cycle of Bacteriophages
Viral Replication: Lysogenic Cycle

